Key result
Elderly patients (>80 years) with atrial fibrillation were less likely to receive oral anticoagulation and had higher 1-year mortality and cardiovascular events compared to younger patients.
Population
5,329 patients with atrial fibrillation enrolled in the Euro Heart Survey on AF across 182 hospitals in 35…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Undertreatment with anticoagulation in octogenarians with AF was linked to higher mortality; leaves open whether age-specific strategies improve outcomes.
Observational (n=5,329)
Yes
Elderly patients with atrial fibrillation are significantly undertreated with oral anticoagulation and rhythm control therapies compared to younger patients, and experience substantially higher 1-year mortality and morbidity.
Fumagalli et al. (2012) conducted an observational in Atrial fibrillation (n=5,329). Older age (>80 years) vs. Younger age (<80 years) was evaluated on Myocardial infarction, new onset heart failure, major bleedings, and mortality. Elderly patients (>80 years) with atrial fibrillation were less likely to receive oral anticoagulation and had higher 1-year mortality and cardiovascular events compared to younger patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: